To provide medical professionals (RN, MD, Pharmacist) with the knowledge and understanding for decision making for the effective utilization of Continuous Renal Replacement Therapy (CRRT) and to allow ...

A recent meta-analysis concluded that continuous renal replacement therapy (CRRT) is not superior to intermittent renal replacement therapy (IRRT) in terms of hemodynamic control, renal recovery ...

The abstract of the RENAL Replacement Therapy study concludes that in critically ill patients with acute kidney injury, treatment with higher-intensity continuous renal replacement therapy did not ...

Under the direction of the Yogi government, devotees are being offered high-level health facilities during the Mahakumbh fair ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

Carpediem offers a miniaturised platform and enhances the precision of neonatal continuous renal replacement therapy.

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge from USD 1,214.6 billion in 2023 to an estimated USD 2,771.6 billion by ...

When prolonged or further complicated, the use of CRRT might become necessary, which is one of the most resource-intensive interventions. Determining the optimal time to discontinue CRRT has been ...

CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...